Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
PM Ridker, SZ Goldhaber, E Danielson… - … England Journal of …, 2003 - Mass Medical Soc
Background Standard therapy to prevent recurrent venous thromboembolism includes 3 to
12 months of treatment with full-dose warfarin with a target international normalized ratio …
12 months of treatment with full-dose warfarin with a target international normalized ratio …
[引用][C] Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
PM RIDKER, SZ GOLDHABER… - The New England …, 2003 - pascal-francis.inist.fr
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous
thromboembolism CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
thromboembolism CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
PM Ridker, SZ Goldhaber, E Danielson… - New England Journal …, 2003 - profiles.wustl.edu
BACKGROUND: Standard therapy to prevent recurrent venous thromboembolism includes 3
to 12 months of treatment with full-dose warfarin with a target international normalized ratio …
to 12 months of treatment with full-dose warfarin with a target international normalized ratio …
[PDF][PDF] Fibrinolytic Therapy in Patients 75 Years and Older With ST-Segment-Elevation Myocardial Infarction. One-Year Follow-up of a Large Prospective Cohort
P Ridker, SZ Goldhaber, E Danielson - ACC CURRENT JOURNAL …, 2003 - academia.edu
Conclusions: In patients age 75 years or older, fibrinolytic therapy in patients with STEMI is
associated with a lower incidence of 1-year death and cerebral bleeding rate (composite) …
associated with a lower incidence of 1-year death and cerebral bleeding rate (composite) …
[引用][C] Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
P RIDKER - N Engl J Med, 2003 - cir.nii.ac.jp
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
PM Ridker, SZ Goldhaber… - The New England …, 2003 - pubmed.ncbi.nlm.nih.gov
Background Standard therapy to prevent recurrent venous thromboembolism includes 3 to
12 months of treatment with full-dose warfarin with a target international normalized ratio …
12 months of treatment with full-dose warfarin with a target international normalized ratio …
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
PM Ridker, SZ Goldhaber, E Danielson… - New England Journal of …, 2003 - elibrary.ru
Previous studies have demonstrated that short-term use of full-dose warfarin is highly
effective ofter a first episode of venous thrombosis, and on the basis of evidence from …
effective ofter a first episode of venous thrombosis, and on the basis of evidence from …
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
PM Ridker, SZ Goldhaber, E Danielson… - The New England …, 2003 - europepmc.org
Background Standard therapy to prevent recurrent venous thromboembolism includes 3 to
12 months of treatment with full-dose warfarin with a target international normalized ratio …
12 months of treatment with full-dose warfarin with a target international normalized ratio …
[引用][C] Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
P Ridker, SZ Goldhaber, E Danielson… - ACC Current Journal …, 2003 - infona.pl
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous
thromboembolism × Close The Infona portal uses cookies, ie strings of text saved by a browser …
thromboembolism × Close The Infona portal uses cookies, ie strings of text saved by a browser …